Relenza® Sentinel Site Monitoring Program in Japan

Clinical trial NCT01199744 · COMPLETED

Trial details

NCT number: NCT01199744
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Influenza, Human

Start date: 2009-11-01
Primary completion: 2009-11-01
Enrollment: 1575

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.